Speaker illustration

Mr Ruud Niklaas Visser

Amsterdam (Netherlands (The))

Engineering of bidirectional cardiomyocyte-specific promoters to independently express two transgenes in AAV gene therapy

Event: HFA Winter Research Meeting 2026

Topic: Gene Therapy, Cell Therapy

Session: Moderated posters session

Thumbnail

Poor in vivo transduction of myocardium by lentiviral vectors is likely caused by a post-entry block of transduction

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Gene Therapy, Cell Therapy

Session: Poster session 2

Thumbnail

ESC 365 is supported by